Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Odelle Technology is a medical technology market access and reimbursement consultancy based in the UK, with an address in France. It is not a typical SaaS platform; instead, it provides HTA, healthcare reimbursement, clinical adoption, and health economics support across the UK, Europe, and the US for MedTech, Biotech, IVD, digital therapeutics, AI health technology, and advanced therapy companies.
Its services cover market access strategy, HTA preparation and submission, clinical coding and reimbursement pathways such as DRG/EBM/OPCS/CCAM/LPPR, HEOR models, budget impact and cost-effectiveness analysis, value evidence dossiers, private insurance pathways, post-market clinical follow-up (PMCF), and engagement with hospital executives, payers, clinical societies, and policymakers. The content also specifically emphasizes reimbursement framework design for digital health, DTx, SaMD, AI tools, and advanced therapies, including areas such as DiGA, PECAN, FDA SaMD, Breakthrough Device, and CPT planning.
The website does not disclose standard packages, pricing, payment methods, or SLAs. Its business model is closer to project-based or consulting services, where users can book a discovery call and request a customized service proposal. For enterprise software procurement concerns such as APIs, permissions, cloud deployment, and third-party integrations, the content provides no information.
Its strengths lie in strong vertical industry depth, coverage of key systems such as NICE, HAS, IQWiG, G-BA, and CMS, and the presentation of numerous client testimonials and successful submission cases. It offers clear value for medical technology companies seeking reimbursement access across multiple countries. Its limitations are that it is not a self-service product, and delivery quality depends on the consulting team; pricing transparency is limited, and there is a lack of information on software-based collaboration, data security certifications, and integration capabilities. In addition, some achievement figures on the pages appear inconsistent, so before formal cooperation, users should request a case list and verifiable references.
It is suitable for medical innovation companies preparing to enter the UK/EU market and needing HTA and reimbursement pathway design, clinical coding, payer interviews, or reimbursement assessments for investment due diligence. It is not suitable for teams looking for a general-purpose SaaS, CRM, or project management tool. Access from mainland China cannot be determined from the available content and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on odelletechnology.com official site.
odelletechnology.com is an United Kingdom Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach odelletechnology.com directly.